◀ Back to PRL

PLA2G1B — PRL

Text-mined interactions from Literome

Bjøro et al., Scand J Clin Lab Invest 1992 : Phospholipase A2 (PLA2) stimulated PRL secretion, while the PLA2 inhibitor quinacrine reduced both thyrotropin releasing hormone (TRH) and vasoactive intestinal peptide (VIP) stimulated PRL release
Ohmichi et al., Neuroendocrinology 1990 : DA at 1 microM did not inhibit the release of [ 3H ] -AA induced by 100 mU/ml phospholipase A2 (PLA2), but it inhibited the release of PRL induced by 100 mU/ml PLA2
Ofenstein et al., Proc Soc Exp Biol Med 1987 (Lymphoma) : Phospholipase A2 either by itself or in the presence of prolactin was without effect
Rillema et al., Horm Metab Res 1986 : Since BPB and quinacrine are known to inhibit the enzyme phospholipase A2 (PLA2), it is possible that ongoing PLA2 activity is essential for prolactin to express its actions on at least certain lactogenic processes
Handwerger et al., Endocrinology 1981 : Phospholipase A2 at concentrations of 0.11 and 11.1 U/ml, also inhibited PRL secretion by 46.2 +/- 2.4 % ( P less than 0.001 ) and 63.9 +/- 1.4 % ( P less than 0.001 ), respectively